ArticleJournal of medicine and life2025
A retrospective study on triggering factors and management of epistaxis - our experience in a tertiary ENT clinic.
Article in Journal of medicine and life, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epistaxis is one of the most frequent ENT emergencies, with complex etiologies ranging from local trauma to systemic conditions. This retrospective study analyzed 1,173 patients who presented with epistaxis at a tertiary ENT center over 5 years. Of these, 260 required admissions. The most common triggering factors were hypertension, anticoagulant/antiaggregant therapy, and postoperative complications. A significant portion (38.46%) of cases were idiopathic. Recurrent bleeding was often associated with high blood pressure and male gender, particularly in the 61-70-year age group. Hereditary hemorrhagic telangiectasia was diagnosed in 11 patients, all requiring repeated interventions. Most anterior nasal bleedings had a good response to conservative measures. Posterior or severe cases of epistaxis may require surgical interventions such as cauterization or argon plasma coagulation. The purpose of this paper is to highlight the importance of individualized management, taking into account the location, etiology, and severity. Proper control of cardiovascular comorbidities and careful postoperative monitoring are essential to reducing recurrence and complications associated with epistaxis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.